<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
64678-211-01
</NDCCode>
<PackageDescription>
1 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) / 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05)
</PackageDescription>
<NDC11Code>
64678-0211-01
</NDC11Code>
<ProductNDC>
64678-211
</ProductNDC>
<ProductTypeName>
VACCINE
</ProductTypeName>
<ProprietaryName>
Biothrax
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Anthrax Vaccine Adsorbed
</NonProprietaryName>
<DosageFormName>
INJECTION, SUSPENSION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
19701104
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA103821
</ApplicationNumber>
<LabelerName>
Emergent BioDefense Operations Lansing, LLC
</LabelerName>
<SubstanceName>
BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS
</SubstanceName>
<StrengthNumber>
100
</StrengthNumber>
<StrengthUnit>
ug/mL
</StrengthUnit>
<Pharm_Classes>
Actively Acquired Immunity [PE], Anthrax Vaccines [Chemical/Ingredient], Live Attenuated Bacillus Anthracis Vaccine [EPC], Vaccines, Attenuated [Chemical/Ingredient]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-11-21
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
19701104
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>